Pheroze Tamboli

Author PubWeight™ 109.55‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol 2002 3.52
2 Primary tumor response to targeted agents in patients with metastatic renal cell carcinoma. Eur Urol 2010 3.20
3 Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med 2015 3.00
4 A phase 2 trial of sunitinib in patients with advanced non-clear cell renal cell carcinoma. Eur Urol 2012 2.77
5 Can we better select patients with metastatic renal cell carcinoma for cytoreductive nephrectomy? Cancer 2010 2.75
6 Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma. J Urol 2008 2.45
7 Distribution of cytokeratins and vimentin in adult renal neoplasms and normal renal tissue: potential utility of a cytokeratin antibody panel in the differential diagnosis of renal tumors. Am J Surg Pathol 2005 2.32
8 Melanoma of the penis, scrotum and male urethra: a 40-year single institution experience. J Urol 2005 2.25
9 Upfront, randomized, phase 2 trial of sorafenib versus sorafenib and low-dose interferon alfa in patients with advanced renal cell carcinoma: clinical and biomarker analysis. Cancer 2010 2.19
10 Micropapillary component in lung adenocarcinoma: a distinctive histologic feature with possible prognostic significance. Am J Surg Pathol 2002 2.15
11 Bilateral testicular germ cell tumors: twenty-year experience at M. D. Anderson Cancer Center. Cancer 2002 1.81
12 Interobserver reproducibility in the diagnosis of invasive micropapillary carcinoma of the urinary tract among urologic pathologists. Am J Surg Pathol 2010 1.73
13 Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients. Cancer 2007 1.69
14 Phase II presurgical feasibility study of bevacizumab in untreated patients with metastatic renal cell carcinoma. J Clin Oncol 2009 1.67
15 Preoperative lymphoscintigraphy and dynamic sentinel node biopsy for staging penile cancer: results with pathological correlation. J Urol 2007 1.65
16 Upper urinary tract tumors with nontransitional histology: a single-center experience. Urology 2006 1.63
17 Mesenchymal neoplasms of the kidney in adults: imaging spectrum with radiologic-pathologic correlation. Radiographics 2010 1.62
18 Cytoreductive nephrectomy in the elderly patient: the M. D. Anderson Cancer Center experience. J Urol 2007 1.59
19 Plasmacytoid urothelial carcinoma: detailed analysis of morphology with clinicopathologic correlation in 17 cases. Am J Surg Pathol 2009 1.55
20 Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma. BJU Int 2007 1.54
21 Percutaneous biopsy of primary tumor in metastatic renal cell carcinoma to predict high risk pathological features: comparison with nephrectomy assessment. J Urol 2010 1.52
22 Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma. J Urol 2007 1.52
23 Limitations of preoperative biopsy in patients with metastatic renal cell carcinoma: comparison to surgical pathology in 405 cases. BJU Int 2012 1.51
24 Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma. Carcinogenesis 2010 1.50
25 Can a durable disease-free survival be achieved with surgical resection in patients with pathological node positive renal cell carcinoma? J Urol 2011 1.49
26 Small cell carcinoma of the kidney: a clinicopathologic study of 14 cases. Hum Pathol 2011 1.48
27 Renal cell carcinoma: diagnosis, staging, and surveillance. AJR Am J Roentgenol 2008 1.35
28 Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays. Int J Cancer 2009 1.33
29 Depressive symptoms and cortisol rhythmicity predict survival in patients with renal cell carcinoma: role of inflammatory signaling. PLoS One 2012 1.30
30 Tumor-to-tumor metastasis: report of 2 cases of metastatic carcinoma to angiomyolipoma of the kidney. Arch Pathol Lab Med 2008 1.28
31 Family history and risk of renal cell carcinoma: results from a case-control study and systematic meta-analysis. Cancer Epidemiol Biomarkers Prev 2009 1.27
32 Thyroid-like follicular carcinoma of the kidney with metastases to the lungs and retroperitoneal lymph nodes. Hum Pathol 2010 1.24
33 Intraluminal polypoid metastasis of renal cell carcinoma in gallbladder mimicking gallbladder polyp. Arch Pathol Lab Med 2010 1.22
34 Morphologic criteria for the diagnosis of prostatic adenocarcinoma in needle biopsy specimens. A study of 250 consecutive cases in a routine surgical pathology practice. Arch Pathol Lab Med 2002 1.20
35 Development and characterization of clinically relevant tumor models from patients with renal cell carcinoma. Eur Urol 2010 1.19
36 Vascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma. Cancer 2010 1.19
37 Handling and staging of renal cell carcinoma: the International Society of Urological Pathology Consensus (ISUP) conference recommendations. Am J Surg Pathol 2013 1.15
38 Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression. Oncogene 2003 1.15
39 Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study. Mycoses 2013 1.15
40 Cytoplasmic sequestration of p27 via AKT phosphorylation in renal cell carcinoma. Clin Cancer Res 2009 1.13
41 Pleomorphic and dedifferentiated leiomyosarcoma: clinicopathologic and immunohistochemical study of 41 cases. Hum Pathol 2009 1.13
42 Early primary tumor size reduction is an independent predictor of improved overall survival in metastatic renal cell carcinoma patients treated with sunitinib. Eur Urol 2011 1.13
43 Clear cell adenocarcinoma of the urinary bladder: a short review. Arch Pathol Lab Med 2009 1.11
44 The mammalian target of rapamycin pathway is widely activated without PTEN deletion in renal cell carcinoma metastases. Cancer 2010 1.10
45 Mucinous tubular and spindle cell carcinoma of kidney is probably a variant of papillary renal cell carcinoma with spindle cell features. Ann Diagn Pathol 2007 1.08
46 Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology. J Urol 2007 1.06
47 Papillary renal cell carcinoma: radiologic-pathologic correlation and spectrum of disease. Radiographics 2009 1.03
48 Squamous cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 16 cases. Hum Pathol 2009 1.02
49 Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma. J Urol 2009 1.02
50 Cytoreductive nephrectomy for T4NxM1 renal cell carcinoma: the M.D. Anderson Cancer Center experience. Urology 2007 0.99
51 Tumor-specific isoform switch of the fibroblast growth factor receptor 2 underlies the mesenchymal and malignant phenotypes of clear cell renal cell carcinomas. Clin Cancer Res 2013 0.98
52 Expression of OCT3/4 in renal medullary carcinoma represents a potential diagnostic pitfall. Am J Surg Pathol 2012 0.98
53 Association between lymph node density and disease specific survival in patients with penile cancer. J Urol 2009 0.98
54 Testicular germ cell tumors with sarcomatous components: an analysis of 33 cases. Am J Surg Pathol 2009 0.97
55 Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor. Am J Surg Pathol 2015 0.97
56 Development of accurate models for individualized prediction of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma. Eur Urol 2012 0.96
57 Pseudosarcomatous and sarcomatous proliferations of the bladder. Hum Pathol 2007 0.95
58 Glandular neoplasms of the urachus: a report of 55 cases emphasizing mucinous cystic tumors with proposed classification. Am J Surg Pathol 2014 0.94
59 Phase I studies of imatinib mesylate combined with cisplatin and irinotecan in patients with small cell lung carcinoma. Cancer 2006 0.93
60 Identifying the risk of disease progression after surgery for localized renal cell carcinoma. BJU Int 2010 0.91
61 Can the number of cores with high-grade prostate intraepithelial neoplasia predict cancer in men who undergo repeat biopsy? Urology 2004 0.91
62 Polyclonal anti-PSA is more sensitive but less specific than monoclonal anti-PSA: Implications for diagnostic prostatic pathology. Am J Clin Pathol 2002 0.88
63 The morphologic spectrum of metastatic prostatic adenocarcinoma to the lung: special emphasis on histologic features overlapping with other pulmonary neoplasms. Am J Clin Pathol 2002 0.88
64 Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma. Cancer 2008 0.88
65 Randomized trial of adjuvant thalidomide versus observation in patients with completely resected high-risk renal cell carcinoma. Urology 2008 0.87
66 Invasive micropapillary carcinoma of the breast metastatic to the urinary bladder and endometrium: diagnostic pitfalls and review of the literature of tumors with micropapillary features. Ann Diagn Pathol 2003 0.87
67 Renal cell carcinoma clinically involving adjacent organs: experience with aggressive surgical management. Cancer 2007 0.86
68 Warty-basaloid carcinoma: clinicopathological features of a distinctive penile neoplasm. Report of 45 cases. Mod Pathol 2010 0.84
69 The prognostic value of angiogenesis and metastasis-related genes for progression of transitional cell carcinoma of the renal pelvis and ureter. Clin Cancer Res 2002 0.84
70 Unexpected atypical findings on CT after radiofrequency ablation for small renal-cell carcinoma and the role of percutaneous biopsy. J Vasc Interv Radiol 2007 0.84
71 Positive vascular wall margins have minimal impact on cancer outcomes in patients with non-metastatic renal cell carcinoma (RCC) with tumour thrombus. BJU Int 2014 0.84
72 Oncocytic renal neoplasms: diagnostic considerations. Clin Lab Med 2005 0.83
73 Contemporary strategies for treating nonhereditary synchronous bilateral renal tumors and the impact of minimally invasive, nephron-sparing techniques. Urol Oncol 2007 0.83
74 Contemporary approach to diagnosis and classification of renal cell carcinoma with mixed histologic features. Chin J Cancer 2012 0.83
75 Redefining pT3 renal cell carcinoma in the modern era: a proposal for a revision of the current TNM primary tumor classification system. Cancer 2007 0.83
76 Mediastinal germ cell tumors with an angiosarcomatous component: a report of 12 cases. Hum Pathol 2010 0.83
77 Kinome expression profiling identifies IKBKE as a predictor of overall survival in clear cell renal cell carcinoma patients. Carcinogenesis 2012 0.83
78 Micropapillary variant of urothelial carcinoma in the upper urinary tract: a clinicopathologic study of 11 cases. Arch Pathol Lab Med 2009 0.81
79 Muscularis mucosae of the urinary bladder revisited with emphasis on its hyperplastic patterns: a study of a large series of cystectomy specimens. Ann Diagn Pathol 2007 0.80
80 Metastatic epithelioid hemangioendothelioma of the penis managed with surgery and interferon-alpha. J Urol 2004 0.80
81 Comparison of subtypes of penile squamous cell carcinoma from high and low incidence geographical regions. Int J Surg Pathol 2009 0.78
82 Thymic carcinoma with rhabdoid features. Ann Diagn Pathol 2003 0.77
83 Role of inflammatory related gene expression in clear cell renal cell carcinoma development and clinical outcomes. J Urol 2011 0.77
84 Phase II trial of pemetrexed plus gemcitabine in patients with locally advanced and metastatic nonclear cell renal cell carcinoma. Am J Clin Oncol 2013 0.77
85 Genomic investigation of etiologic heterogeneity: methodologic challenges. BMC Med Res Methodol 2014 0.76
86 Collision tumor of the kidney composed of clear cell carcinoma and collecting duct carcinoma: report of a case with unusual morphology and clinical follow-up. Chin J Cancer 2014 0.75
87 Multisystem crisis in a patient with presumptive renal cell carcinoma. Clin Genitourin Cancer 2008 0.75